HU166029B - - Google Patents
Info
- Publication number
- HU166029B HU166029B HUTA1257A HUTA001257A HU166029B HU 166029 B HU166029 B HU 166029B HU TA1257 A HUTA1257 A HU TA1257A HU TA001257 A HUTA001257 A HU TA001257A HU 166029 B HU166029 B HU 166029B
- Authority
- HU
- Hungary
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6630172A JPS5512435B2 (cg-RX-API-DMAC10.html) | 1972-07-01 | 1972-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU166029B true HU166029B (cg-RX-API-DMAC10.html) | 1974-12-28 |
Family
ID=13311838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUTA1257A HU166029B (cg-RX-API-DMAC10.html) | 1972-07-01 | 1973-06-01 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3925357A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5512435B2 (cg-RX-API-DMAC10.html) |
| AT (1) | AT325206B (cg-RX-API-DMAC10.html) |
| AU (1) | AU469986B2 (cg-RX-API-DMAC10.html) |
| BE (1) | BE801588A (cg-RX-API-DMAC10.html) |
| CA (1) | CA996548A (cg-RX-API-DMAC10.html) |
| CH (1) | CH573435A5 (cg-RX-API-DMAC10.html) |
| CS (1) | CS168036B2 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2332840A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2190414B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1386566A (cg-RX-API-DMAC10.html) |
| HU (1) | HU166029B (cg-RX-API-DMAC10.html) |
| NL (1) | NL7308048A (cg-RX-API-DMAC10.html) |
| PL (1) | PL92969B1 (cg-RX-API-DMAC10.html) |
| SE (1) | SE402916B (cg-RX-API-DMAC10.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522148U (cg-RX-API-DMAC10.html) * | 1978-07-29 | 1980-02-13 | ||
| EE05735B1 (et) * | 2001-02-24 | 2015-01-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina |
| US20030171424A1 (en) * | 2002-03-07 | 2003-09-11 | Lin Ai J. | Intravenous formulation of artelinic acid for treatment of severe and complicated malaria |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7501426B2 (en) * | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| PE20080251A1 (es) * | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| MX2008014024A (es) | 2006-05-04 | 2008-11-14 | Boehringer Ingelheim Int | Formas poliformas. |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| EP3542801A1 (en) * | 2007-08-17 | 2019-09-25 | Boehringer Ingelheim International GmbH | Purin derivatives for use in the treatment of fap-related diseases |
| PE20091730A1 (es) * | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| KR20200118243A (ko) | 2008-08-06 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR101657960B1 (ko) * | 2008-08-15 | 2016-09-20 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｆａｂ-관련 질환의 치료에 사용하기 위한 푸린 유도체 |
| JP2012502081A (ja) | 2008-09-10 | 2012-01-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病及び関連症状の治療のための組み合わせ治療 |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CN102256976A (zh) | 2008-12-23 | 2011-11-23 | 贝林格尔.英格海姆国际有限公司 | 有机化合物的盐形式 |
| TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
| CN107115530A (zh) | 2009-11-27 | 2017-09-01 | 勃林格殷格翰国际有限公司 | 基因型糖尿病患者利用dpp‑iv抑制剂例如利拉利汀的治疗 |
| CA2797310C (en) | 2010-05-05 | 2020-03-31 | Boehringer Ingelheim International Gmbh | Glp-1 receptor agonist and dpp-4 inhibitor combination therapy |
| EP3124041A1 (en) | 2010-06-24 | 2017-02-01 | Boehringer Ingelheim International GmbH | Diabetes therapy |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| HUE061596T2 (hu) | 2011-07-15 | 2023-07-28 | Boehringer Ingelheim Int | Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| EP3685839A1 (en) | 2012-05-14 | 2020-07-29 | Boehringer Ingelheim International GmbH | Linagliptin for use in the treatment of albuminuria and kidney related diseases |
| EP4151218A1 (en) | 2012-05-14 | 2023-03-22 | Boehringer Ingelheim International GmbH | Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| WO2015128453A1 (en) | 2014-02-28 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Medical use of a dpp-4 inhibitor |
| US10155000B2 (en) | 2016-06-10 | 2018-12-18 | Boehringer Ingelheim International Gmbh | Medical use of pharmaceutical combination or composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1026793A (fr) * | 1949-08-02 | 1953-05-04 | American Cyanamid Co | Procédé de préparation de sels de pénicilline |
| NL6803062A (cg-RX-API-DMAC10.html) * | 1967-03-10 | 1968-09-11 | ||
| US3557094A (en) * | 1968-01-05 | 1971-01-19 | Pfizer & Co C | Substituted alkyl esters of alpha-carboxy aryl penicillins |
| AT290728B (de) * | 1968-09-28 | 1971-05-15 | Takeda Chemical Industries Ltd | Verfahren zur herstellung neuer penicilline |
-
1972
- 1972-07-01 JP JP6630172A patent/JPS5512435B2/ja not_active Expired
-
1973
- 1973-06-01 HU HUTA1257A patent/HU166029B/hu unknown
- 1973-06-07 FR FR7320833A patent/FR2190414B1/fr not_active Expired
- 1973-06-08 NL NL7308048A patent/NL7308048A/xx not_active Application Discontinuation
- 1973-06-19 US US371528A patent/US3925357A/en not_active Expired - Lifetime
- 1973-06-25 CS CS4540A patent/CS168036B2/cs unknown
- 1973-06-28 BE BE132836A patent/BE801588A/xx unknown
- 1973-06-28 SE SE7309138A patent/SE402916B/xx unknown
- 1973-06-28 DE DE2332840A patent/DE2332840A1/de active Pending
- 1973-06-29 AT AT576473A patent/AT325206B/de not_active IP Right Cessation
- 1973-06-29 CH CH955873A patent/CH573435A5/xx not_active IP Right Cessation
- 1973-06-29 CA CA175,329A patent/CA996548A/en not_active Expired
- 1973-07-02 GB GB3147473A patent/GB1386566A/en not_active Expired
- 1973-07-02 AU AU57600/73A patent/AU469986B2/en not_active Expired
- 1973-07-02 PL PL1973163783A patent/PL92969B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA996548A (en) | 1976-09-07 |
| DE2332840A1 (de) | 1974-01-17 |
| CS168036B2 (cg-RX-API-DMAC10.html) | 1976-05-28 |
| FR2190414A1 (cg-RX-API-DMAC10.html) | 1974-02-01 |
| CH573435A5 (cg-RX-API-DMAC10.html) | 1976-03-15 |
| US3925357A (en) | 1975-12-09 |
| AU5760073A (en) | 1975-01-09 |
| PL92969B1 (cg-RX-API-DMAC10.html) | 1977-04-30 |
| GB1386566A (en) | 1975-03-12 |
| JPS5512435B2 (cg-RX-API-DMAC10.html) | 1980-04-02 |
| NL7308048A (cg-RX-API-DMAC10.html) | 1974-01-03 |
| BE801588A (fr) | 1973-12-28 |
| FR2190414B1 (cg-RX-API-DMAC10.html) | 1976-07-02 |
| AU469986B2 (en) | 1976-02-26 |
| AT325206B (de) | 1975-10-10 |
| SE402916B (sv) | 1978-07-24 |
| JPS4925121A (cg-RX-API-DMAC10.html) | 1974-03-06 |